Le Lézard
Classified in: Health
Subject: SVY

The global market for pain management drugs is escalating at 3.88% CAGR during the forecast period of 2019-2027


NEW YORK, Dec. 11, 2018 /PRNewswire/ -- KEY FINDINGS
Pain is a distressing sensory and emotional feeling that occurs due to tissue damage or illness that can take place for short-term (acute pain) to long-term (chronic pain).Pain management drugs market supplies medications and therapies which upon employs an interdisciplinary approach for easing the suffering and improving the quality of life of such victims or patients.

Read the full report: https://www.reportlinker.com/p05649832

The global market for pain management drugs is escalating at 3.88% CAGR during the forecast period of 2019-2027. The market has been valued $ XX millions in its base year of 2018 and is expected to reach an astounding sum of $ XX millions by the end of the forecast period, essentially, 2027.

MARKET INSIGHTS
The factors that are the sole drivers for the growth of the pain management drugs market are the public demand for medications with fewer side-effects and their consequential availability, and the rise in global geriatric population that could increase the use of pain medications are expected to drive the global market for pain management drugs.Alongside these circumstances, with the advancement in technology, there are researchers who are trying to develop abuse-deterrent drugs due to the increase in the number of drug abuse cases globally.

This can pave way for the entry of newer drugs for the said market.Patent expiration of pain relieving drugs can decrease their market value, leading to the decrease in revenue earned for the global market.

This can potentially affect the market growth.

REGIONAL INSIGHTS
The global pain management drugs market has been segmented on the basis of several region regions, which are the North America, Europe, Asia-Pacific and the collective countries from the Rest of the World.North America holds the largest share by revenue $ XX millions in the year 2018.

This is attributable to the fact that this region has a large number of aging inhabitants and favorable regulatory conditions.
But conversely, Asia-Pacific region has the fastest growing market for pain management drugs.

Companies mentioned
1. ABBOTT LABORATORIES
2. ACURA PHARMACEUTICALS, INC.
3. CIPHER PHARMACEUTICALS INC.
4. DAIICHI SANKYO, INC.
5. EGALET CORP.
6. ELI LILLY AND COMPANY
7. GLAXOSMITHKLINE
8. HIKMA PHARMACEUTICALS PLC
9. JOHNSON & JOHNSON
10. LUPIN LTD.
11. PFIZER, INC.
12. PURDUE PHARMA L.P.
13. MERCK & CO., INC.
14. NOVARTIS
15. INSYS THERAPEUTICS, INC.

Read the full report: https://www.reportlinker.com/p05649832

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 01:24
Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 1 phase III clinical trial in the United States. Concurrently, the identical INSPiRE-ICU 2 trial is nearing completion, with 23 of 235...

at 01:17
Quarter 1, 2024 - High profitability and strong cash flow Net sales decreased 4.1% to SEK 34,850m (36,352)Organic growth amounted to -4.0%, of which volume accounted for -1.8% and price/mix -2.2%. Excluding restructuring and exited contracts, volumes...

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...



News published on and distributed by: